Evidence map›Paper›PMID 31823963›Full record

ArticleRevista espanola de salud publica2019

[Monitoring and evaluation of hiv in catalonia, getting closer to the 90-90-90 objectives].

Cristina Agustí Benito, Juliana Reyes-Urueña, Alexis Sentís Fuster, Cinta Folch Toda, Laura Fernàndez-López, Andreu Bruguera Riera, Evelin López-Corbeto, Laia Ferrer Serret, Anna Conway, Sergio Moreno Fornes and 3 more

Open access · greenAbstract read
In one paragraph

Article in Revista espanola de salud publica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Cristina Agustí BenitoCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Juliana Reyes-UrueñaCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Alexis Sentís FusterCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Cinta Folch TodaCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Laura Fernàndez-LópezCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Andreu Bruguera RieraCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Evelin López-CorbetoCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Laia Ferrer SerretCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Anna ConwayCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Sergio Moreno FornesCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Laia Egea-CortésCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Joan Colom FarranPrograma de Prevenció, Control i Atenció al VIH, les ITS i les Hepatitis Víriques (PCAVIHV). Departament de Salut. Generalitat de Catalunya. Barcelona. España.
Jordi Casabona I BarbaràCentre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). Agència de Salut Pública de Catalunya (ASPC). Generalitat de Catalunya. Badalona. Barcelona. España.
Government of Catalonia · ESAgència de Salut Pública de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEpidemiological surveillance of HIV infection allows monitoring its incidence as well as possible epidemiological changes, allowing specific interventions to be planned and their impact monitored. The objective of this article is to describe the results of the monitoring and evaluation of the response to the HIV epidemic in Catalonia, based on data included in the Integrated System of Epidemiological Surveillance of AIDS/HIV and Sexually Transmitted Infections of Catalonia (SIVES).

methodsA descriptive analysis of the data from the different sources of information of the SIVES was performed. The time period was defined based on the availability of data from each of the sources of information included in the analysis. The information was structured according to the conceptual representation of the cascade of HIV care, as described in the World Health Organization consolidated strategic information guidelines for HIV.

resultsOf the total of 4,849 new diagnoses notified (2012-2018), 86% were men, of these; the most frequently reported transmission group was men having sex with men with 65%. The trend in the number of new diagnoses decreased in all transmission groups. It is estimated that in 2018 there were 32,429 people living with HIV in Catalonia, of which 89% were diagnosed, of these, 83% were under follow-up in a specialized unit and 78% of them were under treatment. 73% of people in treatment had suppressed the viral load.

conclusionsSIVES as an integrated system of different sources of strategic information allows monitoring the HIV epidemic in Catalonia and evaluating the response to it, identifying key populations and determinants to acquire HIV, as well as the barriers to which people living with HIV they face to achieve viral suppression.

Indexed as

AdolescentAdultAgedAged, 80 and overContinuity of Patient CareEarly DiagnosisEpidemicsFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedPublic Health SurveillanceSpainYoung AdultContinuum of careEarly diagnosisHealth careHIVMonitoring-evaluationSpainSurveillance

Identifiers

PMID31823963
PMCPMC11582974
OpenAlexW3013246782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.